Press Releases Latest Dec 18, 2024 Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment Press Releases Year None202420232022202120202019201820172016201520142013 Mar 06, 2018 Theratechnologies Announces FDA Approval of Trogarzo Feb 07, 2018 Theratechnologies Announces Financial Results for Fiscal Year 2017 Jan 30, 2018 Theratechnologies to Announce Financial Results for Fiscal year 2017 Nov 13, 2017 Theratechnologies Announces Decision by the FDA to Extend the Ibalizumab Review Period to April 3, 2018 Oct 05, 2017 Theratechnologies Announces Financial Results For The Third Quarter Of 2017 Oct 04, 2017 Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab Presented at IDWeek 2017™ Sep 25, 2017 TheraTechnologies to Announce Financial Results for the Third Quarter of 2017 Sep 18, 2017 IBALIZUMAB Long-Term Safety and Efficacy Data to be Presented at IDWEEK 2017 in SAN DIEGO Aug 03, 2017 Theratechnologies Issues Reminder Regarding Warrant Expiry Aug 03, 2017 Theratechnologies Announces Completion of the Pre-License Inspection of the Ibalizumab Manufacturing Facility First page « Previous page ‹ … Page 24 Page 25 Page 26 Page 27 Current page 28 Page 29 Page 30 Page 31 Page 32 … Next page › Last page » Displaying 271 - 280 of 379
Dec 18, 2024 Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment
Nov 13, 2017 Theratechnologies Announces Decision by the FDA to Extend the Ibalizumab Review Period to April 3, 2018
Oct 04, 2017 Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab Presented at IDWeek 2017™
Sep 18, 2017 IBALIZUMAB Long-Term Safety and Efficacy Data to be Presented at IDWEEK 2017 in SAN DIEGO
Aug 03, 2017 Theratechnologies Announces Completion of the Pre-License Inspection of the Ibalizumab Manufacturing Facility
